COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 1670: Articles 16691-16700  | Next

Prediction of severe COVID-19 cases requiring a ventilator in Tokyo, Japan
Kurita, J., Sugawara, T., Ohksa, Y.
10.1101/2021.03.11.21253431 — Posted: 2021-03-12
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity
Gobeil, S., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Stalls, V., Kopp, M. F., Manne, K., Saunders, K. O., Edwards, R. J., Haynes, B. F., Henderson, R., Acharya, P.
10.1101/2021.03.11.435037 — Posted: 2021-03-12 Discussion: Onsite
The role of connectivity on COVID-19 preventive approaches
Miro Pina, V., Nava-Trejo, J. E., Tobias, A., Nzabarushimana, E., Gonzalez-Casanova, A., Gonzalez-Casanova, I.
10.1101/2021.03.11.21253348 — Posted: 2021-03-12
Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases.
Patone, M., Thomas, K., Hatch, R., Tan, P. S., Liao, W., Coupland, C., Mouncey, P., Harrison, D., Rowan, K., Horby, P., Watkinson, P., Hippisley-Cox, J.
10.1101/2021.03.11.21253364 — Posted: 2021-03-12 Discussion: Offsite
Dynamic versus Continuous Interventions: Optimizing Lockdown Policies for COVID-19
Akinci, K., Fdez, J., Pena-Tapia, E., Witkowski, O.
10.1101/2021.03.10.21253324 — Posted: 2021-03-12
Comprehensive evaluation of the impact of sociodemographic inequalities on adverse outcomes and excess mortality during the COVID-19 pandemic in Mexico City
Antonio-Villa, N. E., Fernandez-Chirino, L., Pisanty-Alatorre, J., Mancilla-Galindo, J., Kammar-Garcia, A., Vargas-Vazquez, A., Gonzalez-Diaz, A., Fermin-Martinez, C. A., Marquez-Salinas, A., Canedo Guerra, E., Bahena-Lopez, J. P., Villanueva-Reza, M., Marquez-Sanchez, J., Jaramillo-Molina, M. E., Gutierrez-Robledo, L. M., Bello-Chavolla, O. Y.
10.1101/2021.03.11.21253402 — Posted: 2021-03-12
Quantifying Contact Patterns in Response to COVID-19 Public Health Measures in Canada
Brankston, G., Merkley, E., Fisman, D. N., Tuite, A. R., Poljak, Z., Loewen, P. J., Greer, A. L.
10.1101/2021.03.11.21253301 — Posted: 2021-03-12
Mean Vitamin D levels in 19 European Countries & COVID-19 Mortality over 10 months
Ahmad, A., Heumann, C., Ali, R., Oliver, T.
10.1101/2021.03.11.21253361 — Posted: 2021-03-12 Discussion: Onsite
Comparing COVID-19 risk factors in Brazil using machine learning: the importance of socioeconomic, demographic and structural factors
Baqui, P., Marra, V., Alaa, A. M., Bica, I., Ercole, A., van der Schaar, M.
10.1101/2021.03.11.21253380 — Posted: 2021-03-12 Discussion: Onsite
Leg-heel chest compression as an alternative for medical professionals in times of COVID-19
Ott, M., Krohn, A., Bilfield, L. H., Dengler, F., Jaki, C., Echterdiek, F., Schilling, T., Heymer, J.
10.1101/2021.03.09.21253220 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).